Patent details
EP3585437 Title: COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY
Basic Information
- Publication number:
- EP3585437
- PCT Application Number:
- EP2018054376
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP187073408
- PCT Publication Number:
- WO2018153980
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY
- French Title of Invention:
- COMBINAISONS DE COPANLISIB AVEC UN ANTICORPS ANTI-PD-1
- German Title of Invention:
- KOMBINATIONEN VON COPANLISIB MIT ANTI-PD-1-ANTIKÖRPER
- SPC Number:
Dates
- Filing date:
- 22/02/2018
- Grant date:
- 21/12/2022
- EP Publication Date:
- 01/01/2020
- PCT Publication Date:
- 30/08/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/12/2022
- EP B1 Publication Date:
- 21/12/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 22/02/2023
- Expiration date:
- 22/02/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/12/2022
- Name:
- Bayer Pharma Aktiengesellschaft
- Address:
- Müllerstrasse 178, 13353 Berlin, Germany (DE)
Inventor
- Name:
- NINGSHU, Liu
- Address:
- Germany (DE)
Priority
- Priority Number:
- 17157835
- Priority Date:
- 24/02/2017
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/5377; A61K 31/519; A61K 45/06; C07K 16/28; A61P 35/00; C07K 16/00; A61K 39/395;
Publication
European Patent Bulletin
- Issue number:
- 202251
- Publication date:
- 21/12/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|